aana glp-1 guidelines 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists What is the pipeline for

New research suggests that weight loss treatments using GLP-1 and dual GLP-1/GIP receptor agonists can lead to significant fat loss while still maintaining lean muscle mass

von Ganzimmun, Biovis oder Medivere

Research Hypotheses Considering the developing links among thyroid issues, cardiovascular risks, and nutritional influences, we suggest the subsequent research hypotheses to direct upcoming investigations: Hypothesis 1: Targeted dietary interventions rich in selenium, zinc, iodine, and vitamin D can reduce cardiovascular risk in individuals with subclinical hypothyroidism or Hashimotos thyroiditis

Dietary therapy in hypertension